In vitro fertilization, also known as IVF, is a complex collection of procedures intended to improve fertility, avoid genetic problems, and facilitate child conception. IVF involves taking mature eggs out of the ovaries and fertilizing them with sperm in a lab. The fertilized egg (or eggs) is subsequently delivered to the uterus. IVF today accounts for 1.6% and 4.5% of all live births in the United States and Europe, respectively. IVF is currently commonly used for the treatment of infertility owing to a variety of factors, including endometriosis, male factor, and unexplained infertility. IVF was originally created as a technique to sidestep irreversible tubal illness. The live birth rate per initiated IVF cycle for women utilizing their own eggs has increased by 18% overall, with the biggest improvements seen in older age groups, according to study by the University of New South Wales (UNSW) medical faculty. For instance, the live birth rate per cycle rose from 19% to 23% among women aged 35 to 39. The live birth rate was 10% in the 40 to 44 age range, which represents a 27% rise over the previous 10 years. On the other hand, gradual increase in infertility rate due to delayed marriages, excessive usage of contraceptives etc. coupled with increasing adoption of in vitro fertilization is expected to provide a strong thrust to the in vitro fertilization market demand during the forecast period. Similar to this, a number of local and regional IVF operators are growing their businesses by opening new IVF facilities around India, which would help the expansion of the fertility market in the nation. For instance, first international-level fertility centre, Mira IVF, was opened in the Indian city of Indore in December 2021. Additionally, the advent of technology such as the application of artificial intelligence advancements in IVF for reproductive medicines, management of infertility to improved options like embryo grading, it is expected to bring change in sperm and egg grading as well as clinical decision making. AI eases the process of in vitro fertilization treatment by human errors and saving time for embryo selection. Thus, AI has gained a foothold in the growth of the global in vitro fertilization market.
Get PDF sample report with related graphs & charts (Pre & post COVID-19 impact analysis): https://www.absolutemarketsinsights.com/request_sample.php?id=1422
Segmental Insights: Global In Vitro Fertilization Market
In vitro fertilization’s market share in 2022 is dominated by conventional IVF. ICSI and conventional IVF are two popular methods for achieving fertilization. IVF has been used for many years to treat infertility. Standard insemination occurs during conventional IVF, and a single spermatozoon is injected into a developed oocyte during ICSI. One of the most often utilized assisted reproductive technology (ART) strategies globally is conventional IVF (c-IVF). However, in recent years, the use of c-IVF for non-male-related infertility issues has drastically decreased in favor of intracytoplasmic sperm injection (ICSI). The in vitro fertilization market is expanding dramatically worldwide as a result of these therapies’ technological advances.
Fertility clinics segment is anticipated to be the fastest growing segment in the global in vitro fertilization market in the upcoming years. Due to the rise in demand for specialized treatments for patients specially curated for the problems they are facing, fertility clinics are gaining huge popularity. Government organizations are also investing into the funding of these clinics to provide advanced treatments as well as facilities for better IVF experience. Moreover, in the past few years, hospital and clinics are incorporating advanced technologies into these treatments. Thus, with the advent of technology the global in vitro fertilization market will experience a huge momentum in the upcoming years.
Speak to our analyst in case of queries before buying this report: https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=1422
Regional Insights: Global In Vitro Fertilization Market
Asia Pacific region is estimated to be the fastest growing region in the in vitro fertilization market during the forecast period 2023-2031. Infertility is a rising concern amongst a huge number of women in countries such as India, China, Japan and many others. According to research it is estimated that India is witnessing a high burden of infertility, with an estimated 30 million couples in the reproductive age suffering from lifetime infertility. Furthermore, with rising awareness, government organizations and healthcare institutions are also introducing various programs and healthcare facilities more accessible to a huge population. Thus, with the above stated factors Asia Pacific region is anticipated to witness exponential growth in the in vitro fertilization market during the forecast period.
View our exclusive press releases on Industry Global News24
Global Animal Genetics Market (2022 – 2030)
Global Cobalt Aluminate Market (2022 – 2030)
Competitors: Global In Vitro Fertilization Market
- A CooperSurgical Fertility Company
- Boston IVF
- Cook
- Esco Micro Pte. Ltd.
- Fujifilm Irvine Scientific
- Genea Biomedx
- IVFtech ApS
- Kitazato Corporation
- OvaScience
- Thermo Fisher Scientific
- Vitrolife AB
- Other Industry Participants
Purchase the latest in-depth Global In Vitro Fertilization Market Report @ https://www.absolutemarketsinsights.com/checkout?id=1422
Global In Vitro Fertilization Market:
By Offerings
- Devices and systems
- Culture Media and reagents
- Equipment and accessories
By Type
- Conventional IVF
- IVF with Intracytoplasmic Sperm Injection (ICSI)
By Procedure Type
- Fresh Donor
- Frozen Donor
- Fresh Non donor
- Frozen non donor
By End Users
- Hospitals and clinics
- Fertility Clinics
- Commercial labs
- Others
By Region
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Request for customization to meet your precise research requirements: https://www.absolutemarketsinsights.com/request_for_customization.php?id=1422
Top Reports:
Global Follicle-Stimulating Hormone (FSH) Market – https://www.absolutemarketsinsights.com/reports/Global-Follicle-Stimulating-Hormone-FSH-Market-2022-2030-1267
Global Estrogen Receptor Agonist Market – https://www.absolutemarketsinsights.com/reports/Global-Estrogen-Receptor-Agonist-Market-2022-%E2%80%93-2030-1114
About Us:
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.
Contact Us:
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-7400-24-24-24, US +1-510-420-1213
Website: www.absolutemarketsinsights.com